Associated with


With the exchangeless Versacross® RF Transseptal Solution

EFFICIENT: Achieved transseptal and LAAC sheath delivery in under 7 mins EXCHANGELESS: Enabled faster LA access with 3-in-1 solution by combining a starter wire, RF transseptal device and exchange rail​ EFFORTLESS: Controlled RF puncture with a single wire​

VersaCross® Radiofrequency System Reduces Time to Left Atrial Access versus Conventional Mechanical Needle study led by Dr. Jacqueline Saw

Watch Dr. Jacqueline Saw speak on this study

Single Solution. No Exchanges.™

Exchangeless solution for access-to-delivery of left heart therapy devices.

†Based on initial retrospective comparative study which found that VersaCross® RF Transseptal Solution delivered LAAC sheath in a mean time of 6.7 mins as compared to 13.4 mins (p=0.002) using BRK™ needle and SL1 sheath. Inohara et al. J Interv Card Electrophys. 2021 DOI: 10.1007/s10840-020-00931-7

VersaCross®️ RF Transseptal Solution is intended for left heart access. VersaCross®️ RF wire is indicated for creating atrial septal defects in the heart. VersaCross®️ Transseptal Sheath is indicated for introducing cardiovascular catheters and guidewires to the left atrium. Referred to here is only one example of several left heart procedures that require transseptal access.

PRM-00756 EN J-1,2 V-1 © Copyright Baylis Medical Company Inc., 2021. Baylis Medical Company Inc. reserves the right to change specifications or to incorporate design changes without notice and without incurring any obligation relating to equipment previously manufactured or delivered. VersaCross, the VersaCross logo, OMNIviz, ‘Single Solution. No Exchanges.’ Zero Fluoro. ‘Zero Compromise.’, Baylis Medical, and the Baylis Medical logo are trademarks and/or registered trademarks of Baylis Medical Company Inc. in the USA and/or other countries. Other trademarks are property of their respective owners. Patents Pending and/or issued. CAUTION: Federal Law (USA) restricts the use of these devices to or by the order of a physician. Before use, consult product labels and Instructions for Use for Indications for Use, Contraindications, Warnings, Precautions, Adverse Events and Directions for Use. Products shown may not be approved in all jurisdictions.